# GO_biological_process_0095: before and after transfer clarification

[All 1,328 cases](../README.md) · [Method](../METHOD.md) · [Summary](../SUMMARY.md) · [Exact reviewer user message](../inputs/GO_biological_process_0095.txt)

**Task:** `GO_biological_process`  
**Author key, unchanged:** **D** — antibiotic biosynthetic process

| Round | Reviewer | Key support | Transfer / lookup | Output usability (canonical status) |
|---|---|---|---|---|
| before | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| before | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |
| after | GPT-6 Luna | supported | lookup-dependent | usable output (valid_review) |
| after | Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | usable output (valid_review) |

**Usable output means format-valid review, not reasoning-supported or biologically correct.** A usable output can classify the question as reasoning-supported, lookup-dependent or uncertain. An output error is a problem with the saved model response; it does not count a defective benchmark question or wrong key. Each saved review is retained in full below. Labels from output errors are displayed as saved and excluded from label statistics. The author key and reviewer evidence were visible to reviewers; this is a review of answerability and key support, not a benchmark-solving score.

## Complete original question

```text
[Protein Sequence]
MGPANSEGTMFDAFSREVGDYYDQANELLRAMFTDNVHYGYWPDPSSIDPLAEAGERMTEQLYERLDVSAGHKVLDVGCGVGKPAAWLARKTGATVKGANVSRNQLEVARDRVRSEGLEDRVSFDLADAMHLPYADDSFDRIWAIESMIHMPDRDQVMREMARVLRPGGRLAIADIVVRGTLDDVATAVVEGFCTLSTARSLEHIDNYPALVEKAGLDLLELTDVSEQTRPTGPAVLPAFDVLLPTLGEEGVAQSKKAWGDMFDLPQYGYVLLTAGKP

[Multiple Choices]
A. intracellular signal transduction
B. negative regulation of G1/S transition of mitotic cell cycle
C. heme catabolic process
D. antibiotic biosynthetic process
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Biological Process Prediction, which is to predict the primary biological process a given protein participates in, as defined by the Gene Ontology (GO) 'Biological Process' branch. A biological process is a series of molecular events that accomplishes a larger biological program, such as cell division or signal transduction. Based on the provided protein sequence, you must select the option that best describes the overall biological objective to which the protein contributes.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Four saved visible reviews

## Before: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt record for methyltransferase GfsG. The record describes it as required for synthesis of macrolide antibiotics FD-891 and FD-892, with cited experimental evidence, supporting antibiotic biosynthesis. The annotation supports the key, though the author’s exact source snapshot is unknown.

Citations as saved: [C5](#evidence-c5), [H4](#evidence-h4), [H5](#evidence-h5).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A soluble bacterial enzyme sequence and possible methyltransferase-like features might favor a metabolic role over cell-cycle regulation, but they do not establish antibiotic biosynthesis or distinguish it reliably from other metabolic processes.


**Missing item-specific fact**

> The protein’s identity as GfsG and its experimentally supported role in FD-891/FD-892 biosynthesis are not provided in the question.


**Reason**

> Selecting D requires the protein-specific pathway assignment; it cannot be derived meaningfully from the sequence and choices alone.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The matched-record functional evidence supports D; none of the other listed choices is supported by the supplied sequence alone.


### Important caveats

- Reviewer-only annotations support the expected answer but were absent from the evaluated model input.
- The exact data source snapshot used by the author is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A soluble bacterial enzyme sequence and possible methyltransferase-like features might favor a metabolic role over cell-cycle regulation, but they do not establish antibiotic biosynthesis or distinguish it reliably from other metabolic processes.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein’s identity as GfsG and its experimentally supported role in FD-891/FD-892 biosynthesis are not provided in the question.",
    "reason": "Selecting D requires the protein-specific pathway assignment; it cannot be derived meaningfully from the sequence and choices alone."
  },
  "case_id": "GO_biological_process_0095",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H4",
      "H5"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt record for methyltransferase GfsG. The record describes it as required for synthesis of macrolide antibiotics FD-891 and FD-892, with cited experimental evidence, supporting antibiotic biosynthesis. The annotation supports the key, though the author’s exact source snapshot is unknown."
  },
  "important_caveats": [
    "Reviewer-only annotations support the expected answer but were absent from the evaluated model input.",
    "The exact data source snapshot used by the author is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched-record functional evidence supports D; none of the other listed choices is supported by the supplied sequence alone."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0095",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt record for methyltransferase GfsG. The record describes it as required for synthesis of macrolide antibiotics FD-891 and FD-892, with cited experimental evidence, supporting antibiotic biosynthesis. The annotation supports the key, though the author’s exact source snapshot is unknown.",
    "evidence_ids": ["C5", "H4", "H5"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A soluble bacterial enzyme sequence and possible methyltransferase-like features might favor a metabolic role over cell-cycle regulation, but they do not establish antibiotic biosynthesis or distinguish it reliably from other metabolic processes.",
    "missing_item_specific_fact": "The protein’s identity as GfsG and its experimentally supported role in FD-891/FD-892 biosynthesis are not provided in the question.",
    "reason": "Selecting D requires the protein-specific pathway assignment; it cannot be derived meaningfully from the sequence and choices alone."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched-record functional evidence supports D; none of the other listed choices is supported by the supplied sequence alone."
  },
  "important_caveats": [
    "Reviewer-only annotations support the expected answer but were absent from the evaluated model input.",
    "The exact data source snapshot used by the author is unknown."
  ]
}
```

</details>

## Before: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry E0D208 (Methyltransferase GfsG, Streptomyces halstedii) is experimentally characterized (ECO:0000269, PubMed:26630077) as a methylase required for synthesis of 16-membered macrolide antibiotics FD-891 and FD-892. The PATHWAY comment explicitly states 'Antibiotic biosynthesis' with experimental evidence. GO:0017000 (antibiotic biosynthetic process) is annotated (IEA via keyword, but underpinned by experimental pathway evidence). The sequence matches the benchmark input exactly (SHA-256 confirmed).

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H4](#evidence-h4), [H5](#evidence-h5), [H6](#evidence-h6), [GO1](#evidence-go1).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a canonical SAM-dependent methyltransferase motif (VLDVGCGVGKP, Rossmann-fold class I MTase) and is a compact 278-aa protein. General biological knowledge allows: (1) eliminating B (G1/S mitotic regulation is strictly eukaryotic; the amino-acid composition—high Ala, Pro, Arg, Gly—indicates a high-GC bacterium, not a eukaryote); (2) eliminating C (heme catabolism proceeds via heme oxygenase ring-opening and biliverdin reductase, not SAM-dependent methylation); (3) distinguishing A from D: small standalone SAM-MTases (~250-350 aa) of this fold class are overwhelmingly characterized as tailoring enzymes in secondary-metabolite/antibiotic biosynthetic pathways in actinomycetes, whereas bacterial methyltransferases in signaling (e.g., CheR chemotaxis MTase) are substantially larger (~600 aa) and have distinct folds. Thus D is the most biologically coherent assignment among the four options.


**Missing item-specific fact**

> Confirmation that this specific methyltransferase methylates macrolide polyketide intermediates (rather than, say, a small-molecule signaling compound) is a protein-specific experimental finding. However, the general enzyme-class/size/organism reasoning sufficiently narrows the four options to make D the best-supported choice without requiring that exact fact.


**Reason**

> The sequence reveals enzyme class (SAM-MTase), approximate organism domain (bacterial, high-GC), and size (small tailoring enzyme). These general biological properties meaningfully distinguish D from the other three options through multi-step reasoning rather than requiring recall of a specific database annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> B is eliminated as a eukaryotic mitotic process inconsistent with a bacterial protein. C is eliminated because heme catabolism does not involve SAM-dependent methyltransferases. A is disfavored because bacterial signaling methyltransferases (e.g., CheR) are much larger and structurally distinct from this small Rossmann-fold MTase. D is the single most defensible option given the enzyme class, size, and inferred organism.


### Important caveats

- The GO:0017000 annotation carries an IEA (Inferred from Electronic Annotation) evidence code via keyword, but the underlying PATHWAY comment is supported by experimental evidence (ECO:0000269, PubMed:26630077).
- The organism (Streptomyces halstedii) is not provided in the model input; inference of bacterial origin relies on amino-acid composition heuristics.
- The reviewer-only evidence was absent from the evaluated model input; the reasoning argument uses only general biological knowledge applicable to the sequence and options.
- The distinction between A and D, while favoring D, is not airtight from sequence alone; a small SAM-MTase could in principle participate in a signaling methylation event, though this is far less common for proteins of this size and fold.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a canonical SAM-dependent methyltransferase motif (VLDVGCGVGKP, Rossmann-fold class I MTase) and is a compact 278-aa protein. General biological knowledge allows: (1) eliminating B (G1/S mitotic regulation is strictly eukaryotic; the amino-acid composition—high Ala, Pro, Arg, Gly—indicates a high-GC bacterium, not a eukaryote); (2) eliminating C (heme catabolism proceeds via heme oxygenase ring-opening and biliverdin reductase, not SAM-dependent methylation); (3) distinguishing A from D: small standalone SAM-MTases (~250-350 aa) of this fold class are overwhelmingly characterized as tailoring enzymes in secondary-metabolite/antibiotic biosynthetic pathways in actinomycetes, whereas bacterial methyltransferases in signaling (e.g., CheR chemotaxis MTase) are substantially larger (~600 aa) and have distinct folds. Thus D is the most biologically coherent assignment among the four options.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Confirmation that this specific methyltransferase methylates macrolide polyketide intermediates (rather than, say, a small-molecule signaling compound) is a protein-specific experimental finding. However, the general enzyme-class/size/organism reasoning sufficiently narrows the four options to make D the best-supported choice without requiring that exact fact.",
    "reason": "The sequence reveals enzyme class (SAM-MTase), approximate organism domain (bacterial, high-GC), and size (small tailoring enzyme). These general biological properties meaningfully distinguish D from the other three options through multi-step reasoning rather than requiring recall of a specific database annotation."
  },
  "case_id": "GO_biological_process_0095",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H4",
      "H5",
      "H6",
      "GO1"
    ],
    "judgment": "supported",
    "reason": "UniProt entry E0D208 (Methyltransferase GfsG, Streptomyces halstedii) is experimentally characterized (ECO:0000269, PubMed:26630077) as a methylase required for synthesis of 16-membered macrolide antibiotics FD-891 and FD-892. The PATHWAY comment explicitly states 'Antibiotic biosynthesis' with experimental evidence. GO:0017000 (antibiotic biosynthetic process) is annotated (IEA via keyword, but underpinned by experimental pathway evidence). The sequence matches the benchmark input exactly (SHA-256 confirmed)."
  },
  "important_caveats": [
    "The GO:0017000 annotation carries an IEA (Inferred from Electronic Annotation) evidence code via keyword, but the underlying PATHWAY comment is supported by experimental evidence (ECO:0000269, PubMed:26630077).",
    "The organism (Streptomyces halstedii) is not provided in the model input; inference of bacterial origin relies on amino-acid composition heuristics.",
    "The reviewer-only evidence was absent from the evaluated model input; the reasoning argument uses only general biological knowledge applicable to the sequence and options.",
    "The distinction between A and D, while favoring D, is not airtight from sequence alone; a small SAM-MTase could in principle participate in a signaling methylation event, though this is far less common for proteins of this size and fold."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "B is eliminated as a eukaryotic mitotic process inconsistent with a bacterial protein. C is eliminated because heme catabolism does not involve SAM-dependent methyltransferases. A is disfavored because bacterial signaling methyltransferases (e.g., CheR) are much larger and structurally distinct from this small Rossmann-fold MTase. D is the single most defensible option given the enzyme class, size, and inferred organism."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0095",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry E0D208 (Methyltransferase GfsG, Streptomyces halstedii) is experimentally characterized (ECO:0000269, PubMed:26630077) as a methylase required for synthesis of 16-membered macrolide antibiotics FD-891 and FD-892. The PATHWAY comment explicitly states 'Antibiotic biosynthesis' with experimental evidence. GO:0017000 (antibiotic biosynthetic process) is annotated (IEA via keyword, but underpinned by experimental pathway evidence). The sequence matches the benchmark input exactly (SHA-256 confirmed).",
    "evidence_ids": ["C5", "C6", "H4", "H5", "H6", "GO1"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a canonical SAM-dependent methyltransferase motif (VLDVGCGVGKP, Rossmann-fold class I MTase) and is a compact 278-aa protein. General biological knowledge allows: (1) eliminating B (G1/S mitotic regulation is strictly eukaryotic; the amino-acid composition—high Ala, Pro, Arg, Gly—indicates a high-GC bacterium, not a eukaryote); (2) eliminating C (heme catabolism proceeds via heme oxygenase ring-opening and biliverdin reductase, not SAM-dependent methylation); (3) distinguishing A from D: small standalone SAM-MTases (~250-350 aa) of this fold class are overwhelmingly characterized as tailoring enzymes in secondary-metabolite/antibiotic biosynthetic pathways in actinomycetes, whereas bacterial methyltransferases in signaling (e.g., CheR chemotaxis MTase) are substantially larger (~600 aa) and have distinct folds. Thus D is the most biologically coherent assignment among the four options.",
    "missing_item_specific_fact": "Confirmation that this specific methyltransferase methylates macrolide polyketide intermediates (rather than, say, a small-molecule signaling compound) is a protein-specific experimental finding. However, the general enzyme-class/size/organism reasoning sufficiently narrows the four options to make D the best-supported choice without requiring that exact fact.",
    "reason": "The sequence reveals enzyme class (SAM-MTase), approximate organism domain (bacterial, high-GC), and size (small tailoring enzyme). These general biological properties meaningfully distinguish D from the other three options through multi-step reasoning rather than requiring recall of a specific database annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "B is eliminated as a eukaryotic mitotic process inconsistent with a bacterial protein. C is eliminated because heme catabolism does not involve SAM-dependent methyltransferases. A is disfavored because bacterial signaling methyltransferases (e.g., CheR) are much larger and structurally distinct from this small Rossmann-fold MTase. D is the single most defensible option given the enzyme class, size, and inferred organism."
  },
  "important_caveats": [
    "The GO:0017000 annotation carries an IEA (Inferred from Electronic Annotation) evidence code via keyword, but the underlying PATHWAY comment is supported by experimental evidence (ECO:0000269, PubMed:26630077).",
    "The organism (Streptomyces halstedii) is not provided in the model input; inference of bacterial origin relies on amino-acid composition heuristics.",
    "The reviewer-only evidence was absent from the evaluated model input; the reasoning argument uses only general biological knowledge applicable to the sequence and options.",
    "The distinction between A and D, while favoring D, is not airtight from sequence alone; a small SAM-MTase could in principle participate in a signaling methylation event, though this is far less common for proteins of this size and fold."
  ]
}
```

</details>

## After: GPT-6 Luna

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence-matched UniProt record identifies the protein as a methylase required for synthesis of macrolide antibiotics FD-891 and FD-892, with cited experimental evidence. Its pathway annotation is antibiotic biosynthesis, supporting D.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

Empty string, as saved.


**Missing item-specific fact**

> That this particular methyltransferase methylates biosynthetic intermediates in antibiotic production, rather than serving another methylation-dependent function.


**Reason**

> The sequence is consistent with a soluble methyltransferase, but that broad enzymatic role does not establish its biological pathway. Methyltransferases can participate in several processes, including signaling and specialized-metabolite synthesis; the sequence alone does not meaningfully distinguish antibiotic biosynthesis from the plausible alternatives.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The target-specific evidence supports D; no other offered process is supported for this protein by the supplied evidence.


### Important caveats

- The reviewer-only source evidence was not part of the original model input and supports the key, not sequence-only answerability.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "That this particular methyltransferase methylates biosynthetic intermediates in antibiotic production, rather than serving another methylation-dependent function.",
    "reason": "The sequence is consistent with a soluble methyltransferase, but that broad enzymatic role does not establish its biological pathway. Methyltransferases can participate in several processes, including signaling and specialized-metabolite synthesis; the sequence alone does not meaningfully distinguish antibiotic biosynthesis from the plausible alternatives."
  },
  "case_id": "GO_biological_process_0095",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record identifies the protein as a methylase required for synthesis of macrolide antibiotics FD-891 and FD-892, with cited experimental evidence. Its pathway annotation is antibiotic biosynthesis, supporting D."
  },
  "important_caveats": [
    "The reviewer-only source evidence was not part of the original model input and supports the key, not sequence-only answerability."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The target-specific evidence supports D; no other offered process is supported for this protein by the supplied evidence."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0095",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence-matched UniProt record identifies the protein as a methylase required for synthesis of macrolide antibiotics FD-891 and FD-892, with cited experimental evidence. Its pathway annotation is antibiotic biosynthesis, supporting D.",
    "evidence_ids": ["C5", "C6"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "",
    "missing_item_specific_fact": "That this particular methyltransferase methylates biosynthetic intermediates in antibiotic production, rather than serving another methylation-dependent function.",
    "reason": "The sequence is consistent with a soluble methyltransferase, but that broad enzymatic role does not establish its biological pathway. Methyltransferases can participate in several processes, including signaling and specialized-metabolite synthesis; the sequence alone does not meaningfully distinguish antibiotic biosynthesis from the plausible alternatives."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The target-specific evidence supports D; no other offered process is supported for this protein by the supplied evidence."
  },
  "important_caveats": [
    "The reviewer-only source evidence was not part of the original model input and supports the key, not sequence-only answerability."
  ]
}
```

</details>

## After: Qwen3.8-Flash-Next-NVFP4

**Output usability:** usable output: format-valid review.
**Canonical saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry (E0D208, Methyltransferase GfsG) explicitly annotates the protein as a 'Methylase required for synthesis of the 16-membered macrolide antibiotics FD-891 and FD-892' with experimental evidence (ECO:0000269, PubMed:26630077 demonstrating in vitro methylation of biosynthetic intermediates). The PATHWAY comment states 'Antibiotic biosynthesis' and the GO annotation GO:0017000 (antibiotic biosynthetic process) is recorded. The sequence matches the benchmark input exactly (278 aa, SHA256 match).

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H4](#evidence-h4), [H5](#evidence-h5), [H6](#evidence-h6), [GO1](#evidence-go1).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a clear Rossmann-fold SAM-dependent methyltransferase motif (GCGVGKP at positions ~65-71), identifying it as a small (~278 aa) bacterial methyltransferase. Option B (negative regulation of G1/S transition) is a eukaryotic cell-cycle process and is eliminated by the bacterial character of the protein (small size, no eukaryotic domains, no nuclear localization signals, no CDK-interaction motifs). Option C (heme catabolic process) is eliminated because heme catabolism is catalyzed by heme oxygenases (Fe-dependent dioxygenases) and biliverdin reductases, not by SAM-dependent methyltransferases. Between A (intracellular signal transduction) and D (antibiotic biosynthetic process): the overwhelming majority of characterized small bacterial SAM-MTases (~200-300 aa, Rossmann fold) are found in secondary metabolite/antibiotic biosynthetic gene clusters (polyketide synthase and NRPS pathways), particularly in Actinomycetes. Signal-transduction methyltransferases in bacteria (e.g., CheR) are a small minority with distinct architectures. The statistical prevalence of methyltransferases in natural-product biosynthetic gene clusters, learned from many other characterized systems (erythromycin, tylosin, doxorubicin clusters, etc.), meaningfully favors D over A. This is a family-level inference from the methyltransferase superfamily and bacterial secondary metabolism, not a lookup of this specific protein's record.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The Rossmann-fold motif is directly visible in the sequence. Elimination of B and C follows from basic enzyme-class and organism-type reasoning. The preference for D over A rests on the well-established biological regularity that small bacterial SAM-MTases are predominantly involved in antibiotic/natural-product biosynthesis, a pattern learned from many other characterized methyltransferases in polyketide and NRPS gene clusters. No target-specific annotation is required.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> Options B and C are clearly eliminable (eukaryotic process; wrong enzyme class). Option A is weakly possible in principle but is disfavored by the strong statistical association of small bacterial SAM-MTases with secondary metabolism. Option D is the most defensible single answer.


### Important caveats

- The GO annotation GO:0017000 carries IEA (Inferred from Electronic Annotation) via UniProtKB keyword, but the underlying pathway comment is supported by experimental evidence (ECO:0000269, PubMed:26630077).
- The model cannot determine the organism (Streptomyces halstedii) from sequence alone, but the reasoning does not require knowing the exact species; the bacterial + methyltransferase + secondary-metabolism-prevalence chain is sufficient.
- The entry was first released in 2025; if the benchmark was constructed earlier, the annotation may not have existed at authoring time, though the underlying publications (2010, 2016) predate the benchmark.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a clear Rossmann-fold SAM-dependent methyltransferase motif (GCGVGKP at positions ~65-71), identifying it as a small (~278 aa) bacterial methyltransferase. Option B (negative regulation of G1/S transition) is a eukaryotic cell-cycle process and is eliminated by the bacterial character of the protein (small size, no eukaryotic domains, no nuclear localization signals, no CDK-interaction motifs). Option C (heme catabolic process) is eliminated because heme catabolism is catalyzed by heme oxygenases (Fe-dependent dioxygenases) and biliverdin reductases, not by SAM-dependent methyltransferases. Between A (intracellular signal transduction) and D (antibiotic biosynthetic process): the overwhelming majority of characterized small bacterial SAM-MTases (~200-300 aa, Rossmann fold) are found in secondary metabolite/antibiotic biosynthetic gene clusters (polyketide synthase and NRPS pathways), particularly in Actinomycetes. Signal-transduction methyltransferases in bacteria (e.g., CheR) are a small minority with distinct architectures. The statistical prevalence of methyltransferases in natural-product biosynthetic gene clusters, learned from many other characterized systems (erythromycin, tylosin, doxorubicin clusters, etc.), meaningfully favors D over A. This is a family-level inference from the methyltransferase superfamily and bacterial secondary metabolism, not a lookup of this specific protein's record.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The Rossmann-fold motif is directly visible in the sequence. Elimination of B and C follows from basic enzyme-class and organism-type reasoning. The preference for D over A rests on the well-established biological regularity that small bacterial SAM-MTases are predominantly involved in antibiotic/natural-product biosynthesis, a pattern learned from many other characterized methyltransferases in polyketide and NRPS gene clusters. No target-specific annotation is required."
  },
  "case_id": "GO_biological_process_0095",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H4",
      "H5",
      "H6",
      "GO1"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry (E0D208, Methyltransferase GfsG) explicitly annotates the protein as a 'Methylase required for synthesis of the 16-membered macrolide antibiotics FD-891 and FD-892' with experimental evidence (ECO:0000269, PubMed:26630077 demonstrating in vitro methylation of biosynthetic intermediates). The PATHWAY comment states 'Antibiotic biosynthesis' and the GO annotation GO:0017000 (antibiotic biosynthetic process) is recorded. The sequence matches the benchmark input exactly (278 aa, SHA256 match)."
  },
  "important_caveats": [
    "The GO annotation GO:0017000 carries IEA (Inferred from Electronic Annotation) via UniProtKB keyword, but the underlying pathway comment is supported by experimental evidence (ECO:0000269, PubMed:26630077).",
    "The model cannot determine the organism (Streptomyces halstedii) from sequence alone, but the reasoning does not require knowing the exact species; the bacterial + methyltransferase + secondary-metabolism-prevalence chain is sufficient.",
    "The entry was first released in 2025; if the benchmark was constructed earlier, the annotation may not have existed at authoring time, though the underlying publications (2010, 2016) predate the benchmark."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options B and C are clearly eliminable (eukaryotic process; wrong enzyme class). Option A is weakly possible in principle but is disfavored by the strong statistical association of small bacterial SAM-MTases with secondary metabolism. Option D is the most defensible single answer."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0095",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry (E0D208, Methyltransferase GfsG) explicitly annotates the protein as a 'Methylase required for synthesis of the 16-membered macrolide antibiotics FD-891 and FD-892' with experimental evidence (ECO:0000269, PubMed:26630077 demonstrating in vitro methylation of biosynthetic intermediates). The PATHWAY comment states 'Antibiotic biosynthesis' and the GO annotation GO:0017000 (antibiotic biosynthetic process) is recorded. The sequence matches the benchmark input exactly (278 aa, SHA256 match).",
    "evidence_ids": ["C5", "C6", "H4", "H5", "H6", "GO1"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a clear Rossmann-fold SAM-dependent methyltransferase motif (GCGVGKP at positions ~65-71), identifying it as a small (~278 aa) bacterial methyltransferase. Option B (negative regulation of G1/S transition) is a eukaryotic cell-cycle process and is eliminated by the bacterial character of the protein (small size, no eukaryotic domains, no nuclear localization signals, no CDK-interaction motifs). Option C (heme catabolic process) is eliminated because heme catabolism is catalyzed by heme oxygenases (Fe-dependent dioxygenases) and biliverdin reductases, not by SAM-dependent methyltransferases. Between A (intracellular signal transduction) and D (antibiotic biosynthetic process): the overwhelming majority of characterized small bacterial SAM-MTases (~200-300 aa, Rossmann fold) are found in secondary metabolite/antibiotic biosynthetic gene clusters (polyketide synthase and NRPS pathways), particularly in Actinomycetes. Signal-transduction methyltransferases in bacteria (e.g., CheR) are a small minority with distinct architectures. The statistical prevalence of methyltransferases in natural-product biosynthetic gene clusters, learned from many other characterized systems (erythromycin, tylosin, doxorubicin clusters, etc.), meaningfully favors D over A. This is a family-level inference from the methyltransferase superfamily and bacterial secondary metabolism, not a lookup of this specific protein's record.",
    "missing_item_specific_fact": "",
    "reason": "The Rossmann-fold motif is directly visible in the sequence. Elimination of B and C follows from basic enzyme-class and organism-type reasoning. The preference for D over A rests on the well-established biological regularity that small bacterial SAM-MTases are predominantly involved in antibiotic/natural-product biosynthesis, a pattern learned from many other characterized methyltransferases in polyketide and NRPS gene clusters. No target-specific annotation is required."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "Options B and C are clearly eliminable (eukaryotic process; wrong enzyme class). Option A is weakly possible in principle but is disfavored by the strong statistical association of small bacterial SAM-MTases with secondary metabolism. Option D is the most defensible single answer."
  },
  "important_caveats": [
    "The GO annotation GO:0017000 carries IEA (Inferred from Electronic Annotation) via UniProtKB keyword, but the underlying pathway comment is supported by experimental evidence (ECO:0000269, PubMed:26630077).",
    "The model cannot determine the organism (Streptomyces halstedii) from sequence alone, but the reasoning does not require knowing the exact species; the bacterial + methyltransferase + secondary-metabolism-prevalence chain is sufficient.",
    "The entry was first released in 2025; if the benchmark was constructed earlier, the annotation may not have existed at authoring time, though the underlying publications (2010, 2016) predate the benchmark."
  ]
}
```

</details>

## Existing project source checks of the old Luna review only

These unchanged notes concern the earlier Luna claims. They do not validate either new review or the old Qwen review. No new scientific adjudication was performed.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Complete reviewer-only evidence and qualifications

All excerpts supplied in the original and revised reviewer user message follow. This material was not available to the original evaluated model. Accession identity came from dataset image-path metadata. Source support and transferable discrimination are separate judgments.

**Applicability metadata, unchanged:**

```json
{
  "requested_accession": "E0D208",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "benchmark_sequence_sha256": "446c919f832e44a2cb7c48c753dd503d70b078244fdd1258da6a8d172c0385a4",
  "benchmark_sequence_length": 278,
  "current_status": "retrieved",
  "current_sequence_comparison": "matched",
  "current_entry_audit": {
    "entryVersion": 29,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2010-11-02",
    "sequenceVersion": 1
  },
  "current_uniprot_release": "2026_03",
  "current_record_sha256": "85a828a87c51921c250c7dfea7e360da93d816eafd568bf000dc2c70ce5c24c0",
  "current_source_sequence_sha256": "446c919f832e44a2cb7c48c753dd503d70b078244fdd1258da6a8d172c0385a4",
  "current_source_sequence_length": 278,
  "historical_status": "retrieved",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "selected_historical_entry_version": 28,
  "selected_historical_version": {
    "accession": "E0D208",
    "database": "Swiss-Prot",
    "entryVersion": 28,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_02/2026_02",
    "lastReleaseDate": "10-Jun-2026",
    "name": "GFSG_STRHA",
    "sequenceVersion": 1
  },
  "selected_historical_record_sha256": "b7192a0f66b33ae1c0454812f81ce6522ffac94ec64111595e98e4c543e8a6ef",
  "selected_historical_source_sequence_sha256": "446c919f832e44a2cb7c48c753dd503d70b078244fdd1258da6a8d172c0385a4",
  "selected_historical_source_sequence_length": 278,
  "latest_at_cutoff_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 28,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "actual_author_source_snapshot": "unknown",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed."
}
```

**Qualifications, unchanged:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D208.json)

```json
{
  "evidence_id": "C1",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/E0D208.json",
  "source_sha256": "85a828a87c51921c250c7dfea7e360da93d816eafd568bf000dc2c70ce5c24c0",
  "retrieved_utc": "2026-11-02T04:27:56.118083+00:00",
  "json_pointer": "/primaryAccession",
  "excerpt": "\"E0D208\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D208.json)

```json
{
  "evidence_id": "C2",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/E0D208.json",
  "source_sha256": "85a828a87c51921c250c7dfea7e360da93d816eafd568bf000dc2c70ce5c24c0",
  "retrieved_utc": "2026-11-02T04:27:56.118083+00:00",
  "json_pointer": "/entryAudit",
  "excerpt": "{\"entryVersion\":29,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2010-11-02\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D208.json)

```json
{
  "evidence_id": "C3",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/E0D208.json",
  "source_sha256": "85a828a87c51921c250c7dfea7e360da93d816eafd568bf000dc2c70ce5c24c0",
  "retrieved_utc": "2026-11-02T04:27:56.118083+00:00",
  "json_pointer": "/organism",
  "excerpt": "{\"lineage\":[\"Bacteria\",\"Bacillati\",\"Actinomycetota\",\"Actinomycetes\",\"Kitasatosporales\",\"Streptomycetaceae\",\"Streptomyces\"],\"scientificName\":\"Streptomyces halstedii\",\"taxonId\":1944}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D208.json)

```json
{
  "evidence_id": "C4",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/E0D208.json",
  "source_sha256": "85a828a87c51921c250c7dfea7e360da93d816eafd568bf000dc2c70ce5c24c0",
  "retrieved_utc": "2026-11-02T04:27:56.118083+00:00",
  "json_pointer": "/proteinDescription",
  "excerpt": "{\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"26630077\",\"source\":\"PubMed\"}],\"value\":\"2.1.1.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\"}],\"value\":\"Methyltransferase GfsG\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D208.json)

```json
{
  "evidence_id": "C5",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/E0D208.json",
  "source_sha256": "85a828a87c51921c250c7dfea7e360da93d816eafd568bf000dc2c70ce5c24c0",
  "retrieved_utc": "2026-11-02T04:27:56.118083+00:00",
  "json_pointer": "/comments/0",
  "excerpt": "{\"commentType\":\"FUNCTION\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"20589823\",\"source\":\"PubMed\"},{\"evidenceCode\":\"ECO:0000269\",\"id\":\"26630077\",\"source\":\"PubMed\"}],\"value\":\"Methylase required for synthesis of the 16-membered macrolide antibiotics FD-891 and FD-892 (PubMed:20589823, PubMed:26630077). In vitro uses S-adenosyl-L-methionine to methylate a number of biosynthetic intermediates in the synthesis of FD-891 (PubMed:26630077)\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D208.json)

```json
{
  "evidence_id": "C6",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/E0D208.json",
  "source_sha256": "85a828a87c51921c250c7dfea7e360da93d816eafd568bf000dc2c70ce5c24c0",
  "retrieved_utc": "2026-11-02T04:27:56.118083+00:00",
  "json_pointer": "/comments/2",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"26630077\",\"source\":\"PubMed\"},{\"evidenceCode\":\"ECO:0000305\",\"id\":\"20589823\",\"source\":\"PubMed\"}],\"value\":\"Antibiotic biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C7

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D208.json)

```json
{
  "evidence_id": "C7",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/E0D208.json",
  "source_sha256": "85a828a87c51921c250c7dfea7e360da93d816eafd568bf000dc2c70ce5c24c0",
  "retrieved_utc": "2026-11-02T04:27:56.118083+00:00",
  "json_pointer": "/references/0",
  "excerpt": "{\"citation\":{\"authors\":[\"Kudo F.\",\"Motegi A.\",\"Mizoue K.\",\"Eguchi T.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"20589823\"},{\"database\":\"DOI\",\"id\":\"10.1002/cbic.201000214\"}],\"citationType\":\"journal article\",\"firstPage\":\"1574\",\"id\":\"20589823\",\"journal\":\"ChemBioChem\",\"lastPage\":\"1582\",\"publicationDate\":\"2010\",\"title\":\"Cloning and characterization of the biosynthetic gene cluster of 16-membered macrolide antibiotic FD-891: involvement of a dual functional cytochrome P450 monooxygenase catalyzing epoxidation and hydroxylation.\",\"volume\":\"11\"},\"evidences\":[{\"evidenceCode\":\"ECO:0000312\",\"id\":\"BAJ16473.1\",\"source\":\"EMBL\"}],\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"A-8890\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence C8

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D208.json)

```json
{
  "evidence_id": "C8",
  "source": "UniProtKB current entry",
  "url": "https://rest.uniprot.org/uniprotkb/E0D208.json",
  "source_sha256": "85a828a87c51921c250c7dfea7e360da93d816eafd568bf000dc2c70ce5c24c0",
  "retrieved_utc": "2026-11-02T04:27:56.118083+00:00",
  "json_pointer": "/references/4",
  "excerpt": "{\"citation\":{\"authors\":[\"Kudo F.\",\"Kawamura K.\",\"Furuya T.\",\"Yamanishi H.\",\"Motegi A.\",\"Komatsubara A.\",\"Numakura M.\",\"Miyanaga A.\",\"Eguchi T.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"26630077\"},{\"database\":\"DOI\",\"id\":\"10.1002/cbic.201500533\"}],\"citationType\":\"journal article\",\"firstPage\":\"233\",\"id\":\"26630077\",\"journal\":\"ChemBioChem\",\"lastPage\":\"238\",\"publicationDate\":\"2016\",\"title\":\"Parallel Post-Polyketide Synthase Modification Mechanism Involved in FD-891 Biosynthesis in Streptomyces graminofaciens A-8890.\",\"volume\":\"17\"},\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"A-8890\"}],\"referenceNumber\":5,\"referencePositions\":[\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"POSSIBLE ACTIVE SITE\",\"BIOPHYSICOCHEMICAL PROPERTIES\",\"PATHWAY\",\"DISRUPTION PHENOTYPE\",\"MUTAGENESIS OF GLU-146; HIS-150 AND ASP-175\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "sequence_comparison": "matched"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28)

```json
{
  "evidence_id": "H1",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28",
  "source_sha256": "b7192a0f66b33ae1c0454812f81ce6522ffac94ec64111595e98e4c543e8a6ef",
  "retrieved_utc": "2026-11-02T04:28:00.650050+00:00",
  "source_locator": "lines 1-12",
  "excerpt": "ID   GFSG_STRHA              Reviewed;         278 AA.\nAC   E0D208;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   02-NOV-2010, sequence version 1.\nDT   28-JAN-2026, entry version 28.\nDE   RecName: Full=Methyltransferase GfsG {ECO:0000305};\nDE            EC=2.1.1.- {ECO:0000269|PubMed:26630077};\nGN   Name=gfsG {ECO:0000303|PubMed:20589823};\nOS   Streptomyces halstedii.\nOC   Bacteria; Bacillati; Actinomycetota; Actinomycetes; Kitasatosporales;\nOC   Streptomycetaceae; Streptomyces.\nOX   NCBI_TaxID=1944;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 28,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28)

```json
{
  "evidence_id": "H2",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28",
  "source_sha256": "b7192a0f66b33ae1c0454812f81ce6522ffac94ec64111595e98e4c543e8a6ef",
  "retrieved_utc": "2026-11-02T04:28:00.650050+00:00",
  "source_locator": "lines 13-21",
  "excerpt": "RN   [1] {ECO:0000312|EMBL:BAJ16473.1}\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].\nRC   STRAIN=A-8890;\nRX   PubMed=20589823; DOI=10.1002/cbic.201000214;\nRA   Kudo F., Motegi A., Mizoue K., Eguchi T.;\nRT   \"Cloning and characterization of the biosynthetic gene cluster of 16-\nRT   membered macrolide antibiotic FD-891: involvement of a dual functional\nRT   cytochrome P450 monooxygenase catalyzing epoxidation and hydroxylation.\";\nRL   ChemBioChem 11:1574-1582(2010).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 28,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28)

```json
{
  "evidence_id": "H3",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28",
  "source_sha256": "b7192a0f66b33ae1c0454812f81ce6522ffac94ec64111595e98e4c543e8a6ef",
  "retrieved_utc": "2026-11-02T04:28:00.650050+00:00",
  "source_locator": "lines 43-53",
  "excerpt": "RN   [5]\nRP   FUNCTION, CATALYTIC ACTIVITY, POSSIBLE ACTIVE SITE, BIOPHYSICOCHEMICAL\nRP   PROPERTIES, PATHWAY, DISRUPTION PHENOTYPE, AND MUTAGENESIS OF GLU-146;\nRP   HIS-150 AND ASP-175.\nRC   STRAIN=A-8890;\nRX   PubMed=26630077; DOI=10.1002/cbic.201500533;\nRA   Kudo F., Kawamura K., Furuya T., Yamanishi H., Motegi A., Komatsubara A.,\nRA   Numakura M., Miyanaga A., Eguchi T.;\nRT   \"Parallel Post-Polyketide Synthase Modification Mechanism Involved in FD-\nRT   891 Biosynthesis in Streptomyces graminofaciens A-8890.\";\nRL   ChemBioChem 17:233-238(2016).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 28,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28)

```json
{
  "evidence_id": "H4",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28",
  "source_sha256": "b7192a0f66b33ae1c0454812f81ce6522ffac94ec64111595e98e4c543e8a6ef",
  "retrieved_utc": "2026-11-02T04:28:00.650050+00:00",
  "source_locator": "lines 54-59",
  "excerpt": "CC   -!- FUNCTION: Methylase required for synthesis of the 16-membered macrolide\nCC       antibiotics FD-891 and FD-892 (PubMed:20589823, PubMed:26630077). In\nCC       vitro uses S-adenosyl-L-methionine to methylate a number of\nCC       biosynthetic intermediates in the synthesis of FD-891\nCC       (PubMed:26630077). {ECO:0000269|PubMed:20589823,\nCC       ECO:0000269|PubMed:26630077}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 28,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28)

```json
{
  "evidence_id": "H5",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28",
  "source_sha256": "b7192a0f66b33ae1c0454812f81ce6522ffac94ec64111595e98e4c543e8a6ef",
  "retrieved_utc": "2026-11-02T04:28:00.650050+00:00",
  "source_locator": "lines 66-67",
  "excerpt": "CC   -!- PATHWAY: Antibiotic biosynthesis. {ECO:0000269|PubMed:26630077,\nCC       ECO:0000305|PubMed:20589823}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 28,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H6

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28)

```json
{
  "evidence_id": "H6",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28",
  "source_sha256": "b7192a0f66b33ae1c0454812f81ce6522ffac94ec64111595e98e4c543e8a6ef",
  "retrieved_utc": "2026-11-02T04:28:00.650050+00:00",
  "source_locator": "lines 88-88",
  "excerpt": "DR   GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 28,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence H7

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28)

```json
{
  "evidence_id": "H7",
  "source": "UniSave archived UniProt entry",
  "url": "https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28",
  "source_sha256": "b7192a0f66b33ae1c0454812f81ce6522ffac94ec64111595e98e4c543e8a6ef",
  "retrieved_utc": "2026-11-02T04:28:00.650050+00:00",
  "source_locator": "lines 89-89",
  "excerpt": "DR   GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "entry_version": 28,
  "sequence_version": 1,
  "sequence_comparison": "matched"
}
```

### Evidence GO1

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO1",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 132339-132351",
  "excerpt": "[Term]\nid: GO:0017000\nname: antibiotic biosynthetic process\nnamespace: biological_process\ndef: \"The chemical reactions and pathways resulting in the formation of an antibiotic, a substance produced by or derived from certain fungi, bacteria, and other organisms, that can destroy or inhibit the growth of other microorganisms.\" [GOC:curators]\nsubset: goslim_metagenomics\nsynonym: \"antibiotic anabolism\" EXACT []\nsynonym: \"antibiotic biosynthesis\" EXACT []\nsynonym: \"antibiotic formation\" EXACT []\nsynonym: \"antibiotic synthesis\" EXACT []\nis_a: GO:0009058 ! biosynthetic process\nis_a: GO:0016999 ! antibiotic metabolic process\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0017000"
}
```

### Evidence GO2

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO2",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 219104-219119",
  "excerpt": "[Term]\nid: GO:0035556\nname: intracellular signal transduction\nnamespace: biological_process\nalt_id: GO:0007242\nalt_id: GO:0007243\nalt_id: GO:0023013\nalt_id: GO:0023034\ndef: \"The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell.\" [GOC:bf, GOC:jl, GOC:signaling, ISBN:3527303782]\nsubset: goslim_drosophila\nsynonym: \"intracellular signal transduction pathway\" NARROW []\nsynonym: \"intracellular signaling cascade\" RELATED [GOC:signaling]\nsynonym: \"intracellular signaling pathway\" RELATED []\nsynonym: \"signal transmission via intracellular cascade\" NARROW []\nis_a: GO:0007165 ! signal transduction\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0035556"
}
```

### Evidence GO3

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO3",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 234882-234896",
  "excerpt": "[Term]\nid: GO:0042167\nname: heme catabolic process\nnamespace: biological_process\ndef: \"The chemical reactions and pathways resulting in the breakdown of heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring.\" [GOC:jl]\nsynonym: \"haem catabolic process\" EXACT []\nsynonym: \"haem catabolism\" EXACT []\nsynonym: \"heme breakdown\" EXACT []\nsynonym: \"heme catabolism\" EXACT []\nsynonym: \"heme degradation\" EXACT []\nxref: Reactome:R-HSA-189483 \"Heme degradation\"\nis_a: GO:0006787 ! porphyrin-containing compound catabolic process\nis_a: GO:0042168 ! heme metabolic process\nis_a: GO:0046149 ! pigment catabolic process\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:0042167"
}
```

### Evidence GO4

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)

```json
{
  "evidence_id": "GO4",
  "source": "Gene Ontology current ontology",
  "url": "https://current.geneontology.org/ontology/go-basic.obo",
  "source_sha256": "b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc",
  "retrieved_utc": "2026-11-01T07:04:24.975173+00:00",
  "source_locator": "lines 558206-558215",
  "excerpt": "[Term]\nid: GO:2000134\nname: negative regulation of G1/S transition of mitotic cell cycle\nnamespace: biological_process\ndef: \"Any signaling pathway that decreases or inhibits the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle.\" [GOC:mtg_cell_cycle]\nis_a: GO:1901991 ! negative regulation of mitotic cell cycle phase transition\nis_a: GO:1902807 ! negative regulation of cell cycle G1/S phase transition\nis_a: GO:2000045 ! regulation of G1/S transition of mitotic cell cycle\nrelationship: negatively_regulates GO:0000082 ! G1/S transition of mitotic cell cycle\n\n",
  "excerpt_format": "literal contiguous OBO lines",
  "source_scope": "current ontology; exact historical benchmark ontology unknown",
  "go_id": "GO:2000134"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_biological_process.json), zero-based source row 95. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
